Contraception and Pregnancy Management in Women with Multiple Sclerosis

To participate in this webinar learners should:

• Take the pretest
• Listen to webinar
• Take the post-test
• Complete follow-up evaluation survey

This is an internet-based activity that should take 1 hour to complete.

Learning Objectives

At the conclusion of this presentation, participants should be able to:

• Demonstrate current knowledge about MS, including symptoms, diagnosis, treatment, and pain management
• Improve health outcomes among patients living with MS
• Counsel and manage the treatment of women with MS using an interdisciplinary approach
• Address the reproductive health issues affecting women with MS, including contraception and pregnancy

Accreditation Information

Physicians

ACCREDITATION
The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION
ARHP designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses:

This activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hour, including up to 0.5 pharmacology hours. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.

Pharmacists:

The Association of Reproductive Health Professionals (ARHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 1.0 contact hour of continuing education credit.

Others:

A certificate of attendance will be issued indicating that this activity is accredited for up to 1 hours of AMA PRA Category 1 Credit^TM.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project is funded through educational grants from EMD Serono, Inc., Pfizer Inc, and Novartis Pharmaceuticals Corporation.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Target Audience

The intended audiences for this activity are women’s health and primary care providers, including physicians, nurse practitioners, nurse-midwives, physician assistants, and other professionals who work in obstetrics/gynecology, neurology, family medicine, and related fields.

Advisory Committee Disclosures

ARHP Staff/Consultant Disclosures